Searched for
THYROCARE TECHNOLOGIES SHARES
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the latest news flow from the Gulf region, the probability is high that we might once again see the bulls attempting a comeback. As u...- JioBlackRock Flexi Cap Fund exits Swiggy, 20 other stocks; adds ICICI Pru AMC and 9 more in MarchJioBlackRock Mutual Fund’s Flexi Cap Fund exited Swiggy and 20 other stocks in March, while adding ICICI Prudential Asset Management Compan...
- Thyrocare Technologies' shares down 67%? Here's why investors shouldn't worryThyrocare Technologies’ shares slumped 66.7% to ₹492 on Friday as they began trading ex-bonus for the recently announced 2:1 bonus issue. T...
- Thyrocare Technologies in focus as shares to trade ex-bonus for 2:1 issueThyrocare Technologies will trade ex-bonus today for its 2:1 bonus share issue, under which investors will receive two additional shares fo...
- Corporate actions: HDFC AMC, Thyrocare Technologies shares to trade ex-bonus next week. Check detailsHDFC Asset Management Company and Thyrocare Technologies will trade ex-bonus next week. Record dates are set for November 26 and November 2...
- Thyrocare promoter sells 10% stake for Rs 667 croreDocon Technologies has divested a 10% stake in Thyrocare Technologies for a substantial Rs 667 crore, bringing its ownership down to 61%. N...
- Thyrocare Technologies shares soar 16% to fresh 52-week high after Q2 PAT grows 82% YoYThyrocare Technologies shares touched a fresh 52-week high on Wednesday after a stellar 82% YoY growth in Q2FY26 PAT. The company's Revenue...
- Thyrocare Technologies shares jump 13% after Q1 PAT surges 60% YoYShares of Thyrocare Technologies surged 13% to hit the day's high of Rs 1,357.85 on the NSE on Thursday following the company's Q1 earnings...
- Thyrocare Technologies shares soar nearly 17% as Q1 results impress D-StreetThyrocare’s pathology and radiology segments’ revenues grew 16% and 15% YoY, respectively. Meanwhile the revenue from partnerships surged 2...
- Fundsmith Emerging Equities sells Thyrocare shares worth Rs 36 croreThe shares were disposed of at an average price of Rs 615.14 apiece on BSE and Rs 614.79 on NSE, taking the combined transaction value to R...
- Buy Thyrocare Technologies, target price Rs 1310: HDFC SecuritiesThyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 5758.02 Crore) operating in Hos...
- Buy Thyrocare Technologies, target price Rs 1231: ICICI SecuritiesThyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 5350.36 Crore) operating in Hos...
- PharmEasy buyout puts Thyrocare in a different league: AnalystsThyrocare is making efforts to bolster its brand visibility through the opening of regional and zonal reference laboratories and branded co...
- PharmEasy to acquire 66% stake in Thyrocare Tech, to make open offer to grab additional 26%PharmEasy claims to be India’s number one online pharmacy and diagnostics brand. Thyrocare prides itself as the largest diagnostic company.
- Reduce Thyrocare Technologies, target price Rs 986: ICICI SecuritiesThyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 6229.41 Crore) operating in Hos...
- Buy Thyrocare Technologies, target price Rs 791: ICICI SecuritiesThyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 3998.13 Crore) operating in Hos...
- Hold Thyrocare Technologies, target price Rs 541: ICICI SecuritiesThe brokerage has reduced the revenue and earnings estimates of the company by 9-26 per cent and 14- 47 per cent for FY21-FY22 given high e...
- Buy Thyrocare Technologies, target price Rs 660: JM FinancialThe brokerage expects Thyrocare to post margin expansion of.520 bps over FY19-22 and a sharp improvement in its return profile.
- Buy Thyrocare Technologies, target Rs 795: Prabhudas LilladherBuy Thyrocare Technologies Ltd. at a price target of Rs 795.
- Thyrocare Technologies helps HNIs make money, Ujjivan Financials fails to do soThyrocare was listed on Monday at a premium of 48% to the offer price, while Ujjivan’s listing gain on Tuesday was just 8%.
Load More
